
|Articles|November 1, 2001
Ciprofloxacin study warns of adverse events
Ciprofloxacin (Cipro), the medicine of choice for treatingcutaneous anthrax as well as other forms of the disease, can cause adversedrug reactions in both the central nervous system and the peripheral nervoussystem, according to studies in The Journal of Pharmacotherapy
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Sister Clinicians Highlight Cross-Specialty Collaboration in Dermatology and Podiatry
2
Expert Tips for Treating Vitiligo Shared at Elevate-Derm Conference
3
A Dual mRNA Vaccine Against Merkel Cell Carcinoma Shows Synergy with PD-1 Blockade
4
Tips for Improving Rosacea Recognition in Patients With Skin of Color at Elevate-Derm
5



















